B. Riley Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,266
Closed -$214K 450
2019
Q1
$214K Buy
+2,266
New +$198K 0.04% 339
2018
Q4
Sell
-17,587
Closed -$1.57M 423
2018
Q3
$1.57M Buy
+17,587
New +$1.55M 0.39% 59
2016
Q1
Sell
-2,925
Closed -$350K 172
2015
Q4
$350K Sell
2,925
-1,151
-28% -$133K 0.45% 78
2015
Q3
$440K Buy
4,076
+614
+18% +$76.2K 0.62% 48
2015
Q2
$400K Buy
3,462
+612
+21% +$70K 0.32% 76
2015
Q1
$328K Buy
2,850
+250
+10% +$29.9K 0.25% 118
2014
Q4
$290K Sell
2,600
-150
-5% -$15.8K 0.24% 109
2014
Q3
$260K Buy
2,750
+450
+20% +$40.6K 0.19% 148
2014
Q2
$197K Hold
2,300
0.13% 217
2014
Q1
$161K Buy
+2,300
New +$182K 0.12% 233

Other funds holding CELG

B. Riley Wealth Management's CELG Position: Q2 2019 in Review

B. Riley Wealth Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,266 shares — an estimated $214K sold.

B. Riley Wealth Management first reported a position in CELG in Q1 2014 and held it in 10 quarters. The position peaked at $1.57M in Q3 2018. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • B. Riley Wealth Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • B. Riley Wealth Management sold 2,266 Celgene Corp shares in Q2 2019, an estimated $214K.
  • B. Riley Wealth Management first reported a position in Celgene Corp in Q1 2014 and held it in 10 quarters.
  • B. Riley Wealth Management's Celgene Corp position peaked at $1.57M in Q3 2018.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on B. Riley Wealth Management's 13F filing for Q2 2019, filed 14 Aug 2019.